The Global Science Era

As international collaboration becomes increasingly common, researchers must work to limit their own biases and let cultural diversity enhance their work.

Written byEphraim M. Govere
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

© ISTOCK.COM/PRAWNYThe Earth’s 195 sovereign states are becoming one scientific global village, where a scientist’s success depends on their willingness to carry out collaborative research with others from around the world. By the mid-1990s, scientific collaboration at institutional, national, and international levels, as indicated by coauthorship of published manuscripts, was doubling every 15 years. And by 2008, the number of internationally coauthored articles was increasing exponentially. In 2013, researchers from The Netherlands, the U.S., South Korea, and the U.K. constructed a global collaboration map that revealed international collaborations involving all the nations in the world and estimated that 25 percent of all scientific papers include authors from multiple countries.

Some international collaborations are complex and massive. For example, the etiologic agent of severe acute respiratory syndrome (SARS) was identified with unprecedented speed in 2003 after the World Health Organization (WHO) assigned the task to a network of researchers from 11 laboratories in nine countries. The Human Genome Project involved the contributions of researchers at 20 institutions in six countries. While such large-scale projects take careful planning and coordination between international team members, analysis has shown that the more countries involved in a scientific collaboration, the greater its impact (J Am Soc Inf Sci Tec, 64:392-404, 2013). As Alice Gast, current president of Imperial College London, wrote in Scientific American in 2012: “While scientists become more specialized as they proceed through their studies, broadening and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies